Azithromycin compared with rifampin for eradication of nasopharyngeal colonization by Neisseria meningitidis

Pediatric Infectious Disease Journal

Volumn 17, Issue 9, 1998, Pages 816-819

  Girgis, Nabil ^a   Sultan, Yehia ^b   Frenck Jr , Robert W ^a   El Gendy, Atef ^a   Farid, Zoheir ^a   Mateczun, Alfred ^a  

^a US Naval Medical Research Unit No 3 Egypt   (Egypt)

^b ABBASSIA FEVER HOSPITAL   (Egypt)

Author keywords

Azithromycin; Neisseria meningitidis; Rifampin

Indexed keywords

AZITHROMYCIN; RIFAMPICIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EGYPT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENINGOCOCCOSIS; NASOPHARYNX; NEISSERIA MENINGITIDIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROAT CULTURE;

ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; ANTIBIOTICS, ANTITUBERCULAR; AZITHROMYCIN; CARRIER STATE; HUMANS; MENINGOCOCCAL INFECTIONS; NASOPHARYNX; NEISSERIA MENINGITIDIS; RIFAMPIN;

EID: 0031670385     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199809000-00013     Document Type: Article

References (19)

1. Peltola H, Mäkelä PH, Kähty H, et al. Clinical efficacy of meningococcus Group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 1977;297:686-91.
2. Gold R, Lepow ML, Goldschneider I, Draper TL, Gotschlich EC. Clinical evaluation of Group A and Group C meningococcal polysaccharide vaccines in infants. J Clin Invest 1975;56: 1536-47.
3. Greenwood MM, Hassan King A, Whittle HC. Prevention of secondary cases of meningococcal disease in household contacts by vaccination. Br Med J 1978;2:1317-9.
4. Committee on Infectious Diseases, American Academy of Pediatrics Infectious Diseases and Immunization Committee, Canadian Paediatric Society. Meningococcal disease prevention and control strategies for practice-based physicians. Pediatrics 1996;97:404-12.
5. Recommendation of the Immunization Practices Advisory Committee (ACIP). Meningococcal vaccines. MMWR 1985;34: 255-9.
6. Guttler RB, Counts GW, Auerts CK, et al. Effect of rifampin and minocycline on meningococcal carrier rates. J Infect Dis 1971;124:199-203.
7. Devine LF, Johnson DP, Hagerman CR, Pierce WE, Rhode SL, Pechinpaugh RO. Rifampin levels in serum and saliva and effect on the meningococcal carrier state. JAMA 1970; 214:1055-9.
8. Band JD, Frazer DW. Adverse effects of two rifampin dosage regimens for the prevention of meningococcal infection. Lancet 1984;1:101-2.
9. Beaty HN. Rifampin and minocycline in meningococcal disease. Rev Infect Dis 1983;5(Suppl 3):S451-8.
10. Dworzak DL, Sanders CC, Horowitz EA, et al. Evaluation of single-dose ciprofloxacin in the eradication of Neisseria meningitidis from nasopharyngeal carriers. Antimicrob Agents Chemother 1988;32:1740-1.
11. Schwartz B. Chemoprophylaxis for bacterial infections: principles of an application to meningococcal Infections. Rev Infect Dis 1991;13(Suppl 2):170-3.
12. Barry AL, Jones RN, Thornsberry C. In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin and clindamycin. Antimicrob Agents Chemother 1988;32:752-4.
13. Neu HC. Clinical microbiology of azithromycin. Am J Med 1991;91(Suppl 3A):125-85.
14. Bauer AW, Kirby WMM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-6.
15. 5. Villanova, PA: National Committee for Clinical Laboratory Standards, 1993: vol13(24).
16. Renkonen O, Sivonen A, Visakorpi R. Effect of ciprofloxacin on carrier rate of Neisseria meningitidis in army recruits in Finland. Antimicrob Agents Chemother 1987;31:962-3.
17. Centers for Disease Control and Prevention. Laboratory based surveillance for meningococcal disease in selected areas, United States 1989-1991. MMWR 1993;42(SS-2):21-30.
18. Nicolle LE, Postl B, Kotelewetz E, et al. Chemoprophylaxis for Neisseria meningitidis in an isolated arctic community. J Infect Dis 1982;145:103-9.
19. Sippel JE, Girgis NI, El Ghoroury A, Wahdan MH, Hablas R, Rahka AE. Prevalence of Neisseria meningitidis serogroups in Egypt. Trop Geogr Med 1973;25:350-4.